Allied Market Research recently published a report, titled, “Diabetic Retinopathy Market by Type (Proliferative Diabetic Retinopathy, Diabetic Macular Edema (DME)), and Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy): Global Opportunity Analysis and Industry Forecast, 2020–2030.” As per the report, the global Diabetic Retinopathy Market was estimated at $3.08 billion in 2020 and is expected to hit $10.78 billion by 2030, registering a CAGR of 13.7% from 2021 to 2030.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2010
Diabetic Retinopathy Market Overview:
Surge in the prevalence of diabetes, rise in the geriatric population, growth in incidence of blindness due to diabetes, and increase in focus on awareness that facilitates early diagnosis to control the diseases drive the growth of the global diabetic retinopathy market. On the other hand, dearth of skilled ophthalmologists and extended approval time for drugs impede the growth to some extent. However, emergence of combined therapies for treatment of diabetic macular edema and the emerging markets of the Asia-Pacific and LAMEA regions are expected to create lucrative opportunities in the industry.
Diabetic Retinopathy Market Segmentation:
On the basis of treatment type, the laser surgeries segment accounted for more than two-fifths of the total market share in 2020, and is projected to dominate by 2030. The steroid implants segment, on the other hand, would exhibit the fastest CAGR of 14.9% during the forecast period.
On the basis of region, the market across North America held the major share in 2020, garnering nearly two-fifths of the global market. The Asia-Pacific region, on the other hand, would manifest the fastest CAGR of 14.4% throughout the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/2010
Diabetic Retinopathy Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Diabetic Retinopathy Market Report:
What is the Diabetic Retinopathy market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Diabetic Retinopathy?
The key market players analyzed in the global diabetic retinopathy market report include Ampio Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. (Bausch Health Companies Inc.), Bayer AG, Kowa Co., Ltd., Novartis, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Alimera Science, Inc., F-Hoffmann-La Roche Ltd., and Abbvie, Inc. These market players have adhered to several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their flair in the industry.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.